Riphah International University has signed a three-year Memorandum of Understanding (MoU) with Beijing-based Tairex Technology Co. Ltd. to explore cooperation in artificial intelligence-enabled healthcare, medical education and research in Pakistan. The agreement establishes a framework for both organisations to examine how emerging AI technologies can be applied across healthcare services and medical institutions, with proposed areas of collaboration covering hospital operations, patient facilitation, clinical training and research. The MoU was signed during a hybrid ceremony connecting Riphah’s Islamabad campus with Tairex’s offices in Beijing. Senior representatives from both organisations participated in the ceremony, marking a formal step in their planned cooperation. Through the agreement, the university and the Chinese technology company intend to explore applications that respond to the needs of Pakistan’s healthcare and medical education sectors. The three-year duration provides a framework for identifying potential projects and areas where the organisations can combine their respective institutional and technological capabilities.
One of the key areas outlined in the agreement is the potential use of AI technologies in hospital services. The proposed cooperation will explore ways to apply artificial intelligence to patient facilitation, hospital management and healthcare delivery. These applications could include examining how digital systems support patients as they access hospital services, assist administrative processes and help healthcare institutions manage different operational activities. AI-enabled tools may also be explored for clinical environments, where technology can support information management and assist healthcare professionals in their work. However, the announcement does not specify a particular hospital, software platform, implementation schedule or deployment target. The agreement instead provides an initial framework for assessing possible applications and identifying opportunities for practical cooperation. Any future hospital-based project would require further planning between the organisations, including decisions about the technology involved, institutional requirements and the conditions under which the proposed systems could be introduced. The partnership is therefore focused at this stage on exploring potential uses rather than announcing the immediate launch of an AI-powered hospital service.
Medical education and professional training form another important part of the MoU. Riphah and Tairex intend to explore AI-based simulation tools that could support medical students in developing clinical knowledge and practical skills. These tools may include virtual clinical scenarios through which students can engage with simulated situations as part of their learning. Such systems can provide opportunities to study different clinical cases, practise decision-making and become familiar with healthcare situations in a controlled educational environment. The organisations also plan to explore opportunities for joint research, particularly initiatives that examine how emerging healthcare technologies can be adapted to Pakistan’s requirements. Collaboration in this area could provide a platform for academic teams and technology specialists to identify relevant research questions, assess possible applications and study the role of AI in medical education and healthcare delivery. The announcement does not provide details about specific research projects, participating departments, student numbers or the availability of simulation systems. Those elements are expected to depend on further discussions and separate arrangements between the two organisations. The three-year agreement nevertheless creates an institutional basis for exploring cooperation between a Pakistani university and a Beijing-based technology company in an area where healthcare and digital technologies increasingly intersect.
Both organisations have also reaffirmed their commitment to patient safety, data privacy and ethical standards as part of the proposed collaboration. These considerations will be important if AI-based tools are eventually introduced into clinical settings or if research activities involve patient information. Riphah and Tairex stated that practical implementation, clinical deployment and any use of patient data will remain subject to separate agreements, alongside relevant institutional, ethical and regulatory approvals. This means the MoU itself does not grant automatic approval for the use of AI systems in hospitals or access to medical records. Further arrangements will be required to define the scope of individual projects, responsibilities of the participating organisations and safeguards governing the handling of sensitive information. The partnership follows earlier reports in October about discussions between Riphah and Tairex concerning the potential introduction of the Chinese company’s Agent Hospital system in Pakistan. The newly announced MoU formalises a broader three-year framework covering hospital services, medical education and research. As the organisations proceed with discussions, the collaboration could create opportunities to assess AI applications for healthcare institutions and academic programmes, while keeping implementation subject to the necessary technical, clinical and regulatory requirements.
Follow the SPIN IDG WhatsApp Channel for updates across the Smart Pakistan Insights Network covering all of Pakistan’s technology ecosystem.